DoW Vision, Translational Research Award
This grant funds research to turn promising eye-related discoveries into drugs, devices, or clinical guidelines ready for clinical trial testing, supporting preclinical or pilot clinical studies aligned with FY26 Vision Research Program priorities.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 28, 2026: Pre-Application (Preproposal) | November 12, 2026: Full Application | November 17, 2026: End of Application Verification Period
Funding Amounts: $1.6M total costs (direct + indirect) per award; maximum period of performance is 3 years; typically 1 award expected.
Summary: Supports translational research advancing promising discoveries in vision injury toward drugs, devices, or clinical guidelines ready for clinical trial testing, with focus on military-relevant visual system trauma.
Key Information: Pre-application is required; full application by invitation only.
Description
The FY26 Vision Research Program (VRP) Translational Research Award (TRA) funds translational research that moves promising basic discoveries into the next stage of development—specifically, toward new drugs, devices, or clinical practice guidelines that will be ready for definitive clinical trials by the end of the funding period. The program targets military-relevant visual system trauma, including ocular injury and vision dysfunction resulting from traumatic brain injury, and seeks to significantly advance prevention, diagnosis, mitigation, or treatment of vision injuries associated with military service.
Distinctive features include the requirement for regulatory expertise if developing drugs or devices, and the option for two Principal Investigators (Partnering PI Option) to collaborate on a single project. The award may support preclinical studies, clinical research, or pilot clinical trials (but not full-scale clinical trials). All research must address at least one of the VRP’s focus areas for FY26.
